Prosecution Insights
Last updated: October 02, 2026

Northstar Medical Technologies, LLC

Technology area: Chemistry & Materials

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Analysis

Northstar Medical Technologies, LLC is navigating 2 pending office actions in the Chemistry & Materials technology area. These actions are split between distinct examiners and 2 distinct art units. KIM, SUN U is the busiest examiner, currently managing 1 pending action.

The distribution across 2 distinct art units indicates that the company's current filings involve diverse chemical or material subjects. This requires a prosecution strategy that can adapt to the specific standards of multiple USPTO groups. For the practitioner, the presence of multiple pending matters allows for the development of distinct technical narratives for each application while maintaining a presence in different art units.

In the Chemistry & Materials sector, navigating the specific requirements of different art units is a common challenge. By managing these actions across the assigned examiners, the applicant can identify the most effective arguments for each technical area. The current prosecution profile reflects the varied nature of the company's patent filings, with each 1 pending action receiving individual attention from the USPTO staff.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
2
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
1
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (50%)
Multi-statute (no §101)1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LACLAIR, LOGAN EDWARD 1 78.2% +22.2%
KIM, SUN U 1 78.2% +11.5%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18513381 METHOD FOR STACKED ELUTION OF MOTHER-DAUGHTER RADIONUCLIDES LACLAIR, LOGAN EDWARD —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18513381 METHOD FOR STACKED ELUTION OF MOTHER-DAUGHTER RADIONUCLIDES LACLAIR, LOGAN EDWARD —
18513220 System and Method For Fractional Elution of Mother-Daughter Radionuclides KIM, SUN U —

Top Art Units

Art UnitApps
1736 1
1777 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18513381 METHOD FOR STACKED ELUTION OF MOTHER-DAUGHTER RADIONUCLIDES LACLAIR, LOGAN EDWARD 1736 §102§112 Non-Final OA — Pending Nov 17, 2023
18513220 System and Method For Fractional Elution of Mother-Daughter Radionuclides KIM, SUN U 1777 §102§112DP Non-Final OA — Pending Nov 17, 2023

Managing Northstar Medical Technologies, LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month